The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2019. This month there are five guidelines and one diagnostic guideline that impact upon primary care.
The Suspected neurological conditions: recognition and referral guideline has been published. It covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.
The Stroke and transient ischaemic attack in over 16s: diagnosis and initial management guideline has been published and it replaces previous guidance from July 2008. It covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms.
The Crohn’s disease: management guideline has been published and it replaces previous guidance from October 2012. It covers the management of Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.
The Ulcerative colitis: management guideline has been published and it replaced previous guidance from June 2013. It covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.
The Prostate cancer: diagnosis and management guideline has been published and it replaces previous guidance from January 2014 and June 2015. It covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.
The Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care diagnostics guidance has been published. It recommends that there is not enough evidence to recommend the routine adoption of lead-I electrocardiogram (ECG) devices to detect atrial fibrillation in primary care. Further research is recommended and centres already using these devices are encouraged to take part in research and data collection.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Drug Safety Update - May 2019||CKS Updates - May 2019 »|